Generic immunoassay of corticosteroids with minimum pre-treatment of urine samples.

This research introduces an efficient, sensitive enzyme linked immunosorbent assay (ELISA) test for detecting synthetic corticosteroids in diluted urine samples with minimal preparation required.

Development of the ELISA Test

• The researchers developed a generic ELISA test aimed at improving the process of examining synthetic corticosteroids such as flumethasone, dexamethasone, and betamethasone.
• Unlike traditional assays, this ELISA can be applied directly to diluted urine samples without having to break down glucuronide or sulfate conjugates or any other prior treatment of samples. In simpler terms, they removed the need for complex pre-tests.

Creation of Polyclonal Antibodies

• Polyclonal antibodies were created through the immunization of sheep with a derivative of flumethasone linked to human serum albumin.
• The resulting polyclonal antibody had high reactivity with several synthetic corticosteroids. This means it was able to recognize and bind to multiple types of corticosteroids.
• However, natural corticosteroids such as cortisol had less than 0.5 percent cross-reactivity, demonstrating the specificity of the antibodies for synthetic compounds.

Sensitivity of the Assay

• Sensitivity refers to the smallest quantity of substance that the assay can effectively detect. For this newly developed ELISA, the sensitivities were 2.5, 3.1, and 12.5 ng/ml for flumethasone, dexamethasone, and betamethasone, respectively.
• This means that the assay can effectively detect very small quantities of these corticosteroids in a sample, making it a useful tool for early detection or low-level monitoring.

Practical Application of the Assay

• The validity and utility of this assay were demonstrated by testing it on urine samples from horses that had been administered synthetic corticosteroids.
• The successful detection in these samples confirmed the test’s potential for practical applications in detecting corticosteroid therapy or misuse in equine sports or treatment protocols.